» Articles » PMID: 31171901

Engineering of Human Corneal Endothelial Cells

Overview
Journal Int J Med Sci
Specialty General Medicine
Date 2019 Jun 8
PMID 31171901
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Human corneal endothelial cells are responsible for controlling corneal transparency, however they are notorious for their limited proliferative capability. Thus, damage to these cells may cause irreversible blindness. Currently, the only way to cure blindness caused by corneal endothelial dysfunction is via corneal transplantation of a cadaver donor cornea with healthy corneal endothelium. Due to severe shortage of donor corneas worldwide, it has become paramount to develop human corneal endothelial grafts that can subsequently be transplanted in humans. Recently, we have reported effective expansion of human corneal endothelial cells by reprogramming the cells into progenitor status through use of p120-Kaiso siRNA knockdown. This new reprogramming approach circumvents the need of using induced pluripotent stem cells or embryonic stem cells. Successful promotion of this technology will encourage scientists to re-think how "contact inhibition" can safely be perturbed to our benefit, i.e., effective engineering of an -like tissue while successful maintaining the normal phenotype. In this review, we present current advances in reprogramming corneal endothelial cells , detail the methods to successful engineer human corneal endothelial grafts, and discuss their future clinical applications to cure corneal blindness.

Citing Articles

Advancements in bioengineering for descemet membrane endothelial keratoplasty (DMEK).

Zwingelberg S, Karabiyik G, Gehle P, von Brandenstein M, Eibichova S, Lotz C NPJ Regen Med. 2025; 10(1):10.

PMID: 39952985 PMC: 11828897. DOI: 10.1038/s41536-025-00396-0.


Polychlorinated Biphenyls Induce Cytotoxicity and Inflammation in an In Vitro Model of an Ocular Barrier.

Cosentino A, Agafonova A, Cavallaro L, Musumeci R, Prinzi C, Lombardo C Int J Mol Sci. 2025; 26(3).

PMID: 39940688 PMC: 11817744. DOI: 10.3390/ijms26030916.


The effects of acute angle closure crisis on corneal endothelial cells in patients with type 2 diabetes mellitus.

Cong L, Pan X, Xia Y, Zhang Y, Cheng J, Dong Y Front Endocrinol (Lausanne). 2022; 13:956780.

PMID: 36111300 PMC: 9468933. DOI: 10.3389/fendo.2022.956780.


Application of dental pulp stem cells in oral maxillofacial tissue engineering.

Liu P, Zhang Y, Ma Y, Tan S, Ren B, Liu S Int J Med Sci. 2022; 19(2):310-320.

PMID: 35165516 PMC: 8795794. DOI: 10.7150/ijms.68494.


Potential Factors of Corneal Endothelial Cells for Progression in Children with Uveitis.

Chen X, Shao Y, Wu S, Zhou S Dis Markers. 2022; 2021:8432774.

PMID: 34992695 PMC: 8727170. DOI: 10.1155/2021/8432774.


References
1.
Hofer-Warbinek R, Schmid J, Stehlik C, Binder B, Lipp J, de Martin R . Activation of NF-kappa B by XIAP, the X chromosome-linked inhibitor of apoptosis, in endothelial cells involves TAK1. J Biol Chem. 2000; 275(29):22064-8. DOI: 10.1074/jbc.M910346199. View

2.
Uddin S, Lekmine F, Sharma N, Majchrzak B, Mayer I, Young P . The Rac1/p38 mitogen-activated protein kinase pathway is required for interferon alpha-dependent transcriptional activation but not serine phosphorylation of Stat proteins. J Biol Chem. 2000; 275(36):27634-40. DOI: 10.1074/jbc.M003170200. View

3.
Senoo T, Obara Y, Joyce N . EDTA: a promoter of proliferation in human corneal endothelium. Invest Ophthalmol Vis Sci. 2000; 41(10):2930-5. View

4.
Murga C, Zohar M, Teramoto H, Gutkind J . Rac1 and RhoG promote cell survival by the activation of PI3K and Akt, independently of their ability to stimulate JNK and NF-kappaB. Oncogene. 2002; 21(2):207-16. DOI: 10.1038/sj.onc.1205036. View

5.
Habas R, Dawid I, He X . Coactivation of Rac and Rho by Wnt/Frizzled signaling is required for vertebrate gastrulation. Genes Dev. 2003; 17(2):295-309. PMC: 195976. DOI: 10.1101/gad.1022203. View